V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007879 | 190006462 | null | 62.3 | null | null | 2019-10-30 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 101522657 |
| 190008183 | 190006463 | 0 | 50.4 | null | 2019-03-28 | 2019-04-13 | PAM x 2 post-surgery (cycles 3&4) | 02 | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101496769 |
| 190008940 | 190006464 | 1.74 | 31 | Palliative (P) | 2017-09-27 | 2017-09-29 | PEMBROLIZUMAB | null | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101338788 |
| 190009318 | 190006466 | 1.58 | 66.7 | Palliative (P) | 2017-09-13 | 2017-09-13 | NB HRNBL-1 COJEC Ind COURSE C | 02 | Y | EW EUROEWING 2012 ARM B VDC/IE | 101263266 |
| 190009411 | 190006467 | 0 | 41 | null | 2019-10-28 | 2019-10-28 | CARBOPLATIN + ETOPOSIDE | 01 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101440369 |
| 190010127 | 190006469 | 0 | 20.5 | null | 2020-04-18 | 2020-05-30 | null | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100767437 |
| 190010137 | 190006470 | 1.55 | 40.2 | Neo-adjuvant (N) | 2019-07-09 | 2019-07-18 | Etoposide + Ifosfamide (5 days) | N | N | ETOPOSIDE + IFOSFAMIDE | 100807503 |
| 190000352 | 190006480 | null | null | null | null | 2016-12-06 | null | null | null | MIFAMURTIDE | 100755051 |
| 190001707 | 190006512 | null | null | null | null | 2018-03-10 | null | null | null | MIFAMURTIDE | 100122404 |
| 190001772 | 190006514 | null | null | null | null | 2019-04-28 | null | null | null | MIFAMURTIDE | 101606927 |
| 190001864 | 190006520 | null | 76.7 | null | null | 2016-12-19 | null | 02 | null | MIFAMURTIDE | 100345073 |
| 190003091 | 190006545 | 0 | 100.1 | null | 2017-02-23 | 2017-02-23 | null | null | null | MIFAMURTIDE | 100560924 |
| 190003331 | 190006553 | null | null | null | null | 2017-09-02 | null | null | null | MIFAMURTIDE | 101564721 |
| 190004322 | 190006578 | null | null | null | null | 2021-01-24 | null | null | null | MIFAMURTIDE | 100490104 |
| 190005082 | 190006611 | null | null | Curative (C) | null | 2018-05-21 | null | null | null | MIFAMURTIDE | 101284869 |
| 190005112 | 190006614 | null | null | null | null | 2019-07-01 | null | null | null | MIFAMURTIDE | 101386468 |
| 190005188 | 190006618 | null | null | Adjuvant (A) | null | 2019-11-19 | null | null | null | MIFAMURTIDE | 101215574 |
| 190005213 | 190006622 | 1.71 | 76 | null | 2016-11-29 | 2017-01-07 | null | null | null | MIFAMURTIDE | 100948012 |
| 190005269 | 190006625 | null | null | Curative (C) | null | 2021-09-11 | null | null | null | MIFAMURTIDE | 100608621 |
| 190005325 | 190006628 | null | null | null | null | 2020-08-07 | null | null | null | MIFAMURTIDE | 100290841 |
| 190005483 | 190006637 | null | null | null | null | 2018-07-15 | null | null | null | MIFAMURTIDE | 100297249 |
| 190005508 | 190006639 | null | null | null | null | 2019-11-03 | null | null | null | MIFAMURTIDE | 101159688 |
| 190005856 | 190006671 | null | null | null | null | 2021-03-08 | null | null | null | MIFAMURTIDE | 101128844 |
| 190006309 | 190006698 | null | null | Neo-adjuvant (N) | null | 2020-04-30 | null | null | null | MIFAMURTIDE | 100526324 |
| 190006415 | 190006707 | null | null | null | null | 2019-03-30 | null | null | null | MIFAMURTIDE | 100701975 |
| 190006823 | 190006752 | 0 | 27.2 | Curative (C) | 2019-02-15 | 2019-02-22 | NIVOLUMAB | 02 | null | CARBOPLATIN + THIOTEPA + TOPOTECAN | 101504882 |
| 190006829 | 190006753 | null | 42.9 | null | 2016-11-25 | 2016-11-25 | STS Non-Rhabdo EpSSG 2005 Vcy | 02 | N | CISPLATIN + GEMCITABINE | 100921122 |
| 190006853 | 190006754 | 1.65 | null | null | 2021-01-17 | 2021-10-16 | Carboplatin + Etoposide IV 3 day | 02 | Y | FLUOROURACIL + IRINOTECAN | 101813862 |
| 190006855 | 190006755 | 1.63 | 72.4 | null | 2018-05-26 | 2018-05-26 | null | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101250750 |
| 190006869 | 190006756 | 1.52 | 67 | Curative (C) | 2016-07-21 | 2016-08-06 | VAI (Ifos 3g/m2) | 01 | N | PACLITAXEL | 101142086 |
| 190006880 | 190006757 | 1.51 | 59.4 | null | 2021-06-01 | 2021-06-20 | Cyclophosphamide + Vincristine | N | Y | TRABECTEDIN | 100352964 |
| 190006887 | 190006758 | 1.78 | 66.05 | Curative (C) | 2017-07-08 | 2017-11-09 | EW EuroEwing 2012 Arm A VAI | N | Y | CAPECITABINE | 100625828 |
| 190006897 | 190006759 | 1.76 | 75.3 | Palliative (P) | 2021-05-18 | 2021-07-14 | EW EuroEwing 2012 Arm A VAI | 01 | N | CISPLATIN + FLUOROURACIL + RT | 100842510 |
| 190006919 | 190006760 | 1.8 | 112.1 | null | null | 2020-03-31 | Capecitabine | 02 | null | DOCETAXEL | 101018181 |
| 190006927 | 190006761 | null | 79.8 | Curative (C) | null | 2018-07-12 | ETOPOSIDE | 01 | null | CAPECITABINE + OXALIPLATIN | 100395443 |
| 190006929 | 190006762 | 1.8 | 52 | Palliative (P) | null | 2018-11-05 | EW EuroEwing 99 : VIDE | null | null | CISPLATIN + GEMCITABINE | 101030233 |
| 190006961 | 190006763 | null | 57 | Neo-adjuvant (N) | 2019-07-24 | 2019-08-14 | Cisplatin + Radiotherapy | N | N | CISPLATIN | 101243207 |
| 190006963 | 190006764 | 1.67 | 78 | Palliative (P) | null | 2016-11-03 | ETOPOSIDE | 02 | N | PACLITAXEL | 100403203 |
| 190006966 | 190006765 | 1.57 | 26.1 | Palliative (P) | 2019-09-06 | 2019-09-24 | OST Euramos 1 Closed Trial - M | 02 | null | DOCETAXEL | 100549979 |
| 190006993 | 190006766 | 0 | 68.8 | Palliative (P) | 2018-09-07 | 2018-09-08 | CAPECITABINE + TEMOZOLOMIDE | 02 | null | PEMBROLIZUMAB | 100530857 |
| 190007039 | 190006767 | null | 80.3 | Curative (C) | 2018-09-06 | 2018-12-16 | OST Mifamurtide | Y | null | CISPLATIN + GEMCITABINE | 101850175 |
| 190007040 | 190006768 | 0 | 65.8 | Adjuvant (A) | 2016-07-05 | 2016-08-02 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101242287 |
| 190007048 | 190006769 | 1.55 | 76.8 | 03 | 2020-01-22 | 2020-01-22 | CARBOPLATIN | 02 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 100592254 |
| 190007074 | 190006770 | 1.71 | 79.6 | Adjuvant (A) | 2017-06-25 | 2017-11-28 | DOXORUBICIN + METHOTREXATE + MIFAMURTIDE | 02 | null | CARBOPLATIN + NAB-PACLITAXEL | 101476057 |
| 190007094 | 190006771 | null | 57.1 | Curative (C) | null | 2016-04-20 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | null | OXALIPLATIN + MDG | 101125341 |
| 190007099 | 190006772 | 1.7 | 73.8 | Neo-adjuvant (N) | 2017-12-25 | 2017-12-28 | Trial Unspecified | 02 | Y | FLUOROURACIL + IRINOTECAN | 101217179 |
| 190007102 | 190006773 | 1.8 | 68.5 | Palliative (P) | 2017-07-03 | 2017-07-03 | Cyclophosphamide oral | 01 | N | CAPECITABINE + OXALIPLATIN | 100863813 |
| 190007162 | 190006774 | 1.78 | 74.6 | Curative (C) | 2019-06-30 | 2019-06-30 | CARBOPLATIN + RT | 02 | N | CARBOPLATIN | 101172818 |
| 190007166 | 190006775 | 1.74 | 70 | Curative (C) | null | 2018-01-26 | Doxorubicin + Methotrexate | 02 | N | LIPOSOMAL DOXORUBICIN | 100421778 |
| 190007192 | 190006776 | 1.78 | 91.2 | Neo-adjuvant (N) | 2021-07-14 | 2021-11-08 | CYCLO + DOXORUBICIN + VINCRISTINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100554476 |